SOX9 and diffuse large B-cell lymphoma: However, SOX9 is overexpressed in certain types of B-cell lymphomas, like Diffused Large B-cell Lymphoma (DLBCL), where it acts as an oncogene by promoting cell proliferation, inhibiting apoptosis, and contributing to the cancer’s progression (Shen et al., 2022).